This site is using Google Analytics to increase its usability. If you take issue with the collection of your data, you can either visit  this page to install an addon that prevents the use of Google Analytics on all pages or simply click this link to prevent the collection of your data on this site only.

ICRC-Weyer at BB Life Seminar dealing with the new EU regulation 536/2014

Yesterday, our colleagues of ICRC-Weyer participated in the BB Life Seminar dealing with the new EU regulation 536/2014 on clinical trials on medicinal products for human use.

The EU regulation is valid since 2014. However, it will be applied earliest this year. The seminar informed about the new legal situation in conducting clinical trials and presented a general view on step changes in contrast to the previous guideline 2001/20/EG as well as its utilization.

Additionally, the participants were informed about the current legal situation of medicinal products in Germany and the manufacturing of investigational products in clinical trials.

This site is using Google Analytics to increase its usability. If you take issue with the collection of your data, you can either visit  this page to install an addon that prevents the use of Google Analytics on all pages or simply click this link to prevent the collection of your data on this site only.